Boston Scientific (BSX) vs West Pharmaceutical Services (WST)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
West Pharmaceutical Services (WST) has outperformed Boston Scientific (BSX) over the past year, gaining 35.6% versus a loss of 56.6%. Over five years, BSX leads with a -3.1% price change compared with -10.3% for WST. Boston Scientific is the larger company by market cap ($61.93 billion vs $25.76 billion), about 2.4 times the size.
On valuation, Boston Scientific trades at a lower forward P/E (12.6x vs 36.6x for West Pharmaceutical Services). West Pharmaceutical Services pays a dividend yielding 0.24%, while Boston Scientific does not currently pay one. West Pharmaceutical Services converts more of its revenue into profit, with a net margin of 16.1% versus 14.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BSX | WST |
|---|---|---|
| Share price | $42.73 | $366.00 |
| Market cap | $61.93B | $25.76B |
| 1-day change | +1.64% | +0.75% |
| YTD return | -55.91% | +32.03% |
| 1-year return | -56.57% | +35.58% |
| 5-year return | -3.13% | -10.26% |
| P/E ratio (TTM) | 17.30 | 46.86 |
| Forward P/E | 12.63 | 36.62 |
| EPS (TTM) | $2.47 | $7.81 |
| Dividend yield | 0.00% | 0.24% |
| Annual dividend | $0.00 | $0.87 |
| Revenue (latest FY) | $20.07B | $3.07B |
| Revenue growth (YoY) | +19.87% | +6.25% |
| Net income (latest FY) | $2.89B | $493.70M |
| Gross margin | 69.01% | 35.91% |
| Operating margin | 18.00% | 19.03% |
| Net margin | 14.41% | 16.06% |
| 52-week high | $105.65 | $386.00 |
| 52-week low | $41.39 | $223.83 |
| Distance from 52-week high | -59.56% | -5.18% |
| Analyst consensus | buy | strong_buy |
| Avg. price target upside | +40.18% | +12.30% |
| Average volume | 19.87M | 625.67K |
| Shares outstanding | 1.45B | 70.38M |
| Employees | 59,000 | 10,800 |
| Sector | Health Care | Health Care |
| Industry | Medical/Dental Instruments | Medical/Dental Instruments |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Boston Scientific is about 2.4 times larger than West Pharmaceutical Services by market value ($61.93B vs $25.76B).
- WST has outperformed BSX by 92.1 percentage points over the past year.
- West Pharmaceutical Services trades at a higher earnings multiple (46.9x vs 17.3x trailing P/E).
- Boston Scientific grew revenue faster in its latest fiscal year (+19.87% vs +6.25%).
About Boston Scientific
BSX stock →Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. The company operates in two segments, MedSurg and Cardiovascular.
Health Care · Medical/Dental Instruments · 59,000 employees
About West Pharmaceutical Services
WST stock →West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific.
Health Care · Medical/Dental Instruments · 10,800 employees
BSX vs WST FAQ
Which is bigger, Boston Scientific or West Pharmaceutical Services?
Boston Scientific (BSX) is larger, with a market capitalization of $61.93B compared with $25.76B for West Pharmaceutical Services (WST).
Which stock has performed better over the past year, BSX or WST?
WST returned +35.58% over the past 12 months, compared with -56.57% for BSX (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, BSX or WST?
BSX has the lower trailing P/E at 17.3, versus 46.9 for WST. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Boston Scientific or West Pharmaceutical Services?
West Pharmaceutical Services pays a dividend yielding 0.24%, while Boston Scientific does not currently pay a regular dividend.
Are Boston Scientific and West Pharmaceutical Services in the same industry?
Yes. Both are classified in the Medical/Dental Instruments industry within the Health Care sector.